Loading...
Safe eradication of large established tumors using neovasculature‐targeted tumor necrosis factor‐based therapies
Systemic toxicities have severely limited the clinical application of tumor necrosis factor (TNF) as an anticancer agent. Activity‐on‐Target cytokines (AcTakines) are a novel class of immunocytokines with improved therapeutic index. A TNF‐based AcTakine targeted to CD13 enables selective activation...
Na minha lista:
| Udgivet i: | EMBO Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7709889/ https://ncbi.nlm.nih.gov/pubmed/31912630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201911223 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|